A phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer

European Journal of Cancer Part A

Volumn 32, Issue 11, 1996, Pages 1933-1937

  Ychou, M ^a   Astre, C ^a   Rouanet, Ph ^a   Fabre, J M ^b   Saint Aubert, B ^a   Domergue, J ^b   Ribard, D ^b   Ciurana, A J ^b   Janbon, Ch ^b   Pujol, H ^a  

^a CENTRE VAL D AURELLE   (France)

^b NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

Chemotherapy; Gastric cancer cancer; Phase II study

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH CANCER; VOMITING;

EID: 0030272752     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00147-5     Document Type: Article

References (19)

1. 1. Wils JA, Klein HO, Wagener DJTh, et al. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - a step ahead in the treatment of advanced gastric cancer: a trial of the European Organisation for Research and Treatment of Cancer Gastro-Intestinal Tract Cancer Cooperative Group. J Clin Oncol 1991, 9, 827-831.
2. 2. Preusser P, Wilke H, Achterrat HW, et al. Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 1989, 7, 1310-1317.
3. 3. Kelsen D, Atiq O, Saltz L, et al. FAMTX versus etoposide, doxorubicin and cisplatin: a random assignment in gastric cancer. J Clin Oncol 1992, 10, 541-548.
4. 4. Rougier Ph, Ducreux M, Mahjoubi M, et al. Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis. Eur J Cancer 1994, 30A, 1263-1269.
5. 5. Lacave AJ, Anton-Aparicio L, Gonzales-Baron M, et al. Cisplatin (CDDP) and 5-fluorouracil (5FU) 120 hr infusion for advanced gastric cancer (GC): a phase II multicenter study. Proc Am Soc Clin Oncol 1987, 6, 91.
6. 6. Findlay M, Cunningham D, Norman A, et al. A phase II study in advanced gastro-oesophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 1994, 5, 609-613.
7. 7. Zaniboni A, Barni S, Labianca R, et al. Epirubicin, cisplatin and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. Cancer 1995, 76, 1694-1699.
8. 8. Machover D, Goldschmidt E, Chollet P, et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 1986, 4, 685-696.
9. 9. Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 1989, 7, 1407-1418.
10. 10. Erlichman C, Fine S, Wong A, et al. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988, 6, 469-475.
11. 11. Poon MA, O'Connell MJ, Wieand HS, Krook JE, Gerstner JB, Tschetter LK. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 1991, 9, 1967-1972.
12. 12. Miller AB, Hoogstratten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981, 47, 2507-2514.
13. 13. Mantel N. Chi-square tests with one degree of freedom; extension of the Mantel-Haenszel procedure. J Am Stat Assoc 1963, 58, 690-700.
14. 14. Kaplan EI, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 5457-5481.
15. 15. Wilke H, Preusser P, Fink U, et al. New developments in the treatment of gastric carcinoma. Semin Oncol 1990, 17 (Suppl 2), 61-70.
16. 16. Murad A, Santiago F, Petroianu A, Rocha P, Rodrigues M, Raush M. Modified therapy with 5-fluorouracil, doxorubicin and methotrexate in advanced gastric cancer. Cancer 1993, 72, 37-41.
17. 17. Pyrhönen S, Kuitinen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995, 71, 587-591.
18. 18. Kim NK, Park YS, Heo DS, et al. A phase III randomised study of 5-fluorouracil and cisplatin versus 5-flourouracil, doxorubicin and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer 1993, 71, 3813-3818.
19. 19. Rougier Ph, Wils J, Wilke A, et al. Advanced gastric cancer: comparison of FAMTX versus ELF versus FUP. Results from an EORTC trial of the GITCCG and the Arbeitsgemenschaft Fûr Innere Onkologie (AIO). Eur J Cancer 1995, 31A, 546.